Adiponectin protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity

Biochemical Pharmacology

Volumn 72, Issue 5, 2006, Pages 616-623

  Jung, Tae Woo ^a   Lee, Ji Young ^b   Shim, Wan Sub ^b   Kang, Eun Seok ^b   Kim, Jong Sun ^b   Ahn, Chul Woo ^a,b   Lee, Hyun Chul ^a,b   Cha, Bong Soo ^a,b  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Acetaldehyde; Adiponectin; Apoptosis; Parkinson's disease; ROS; SH SY5Y

Indexed keywords

ACETALDEHYDE; ADIPONECTIN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETALDEHYDE; ADIPONECTIN; APOPTOSIS; CASPASE 3; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; HUMANS; NEUROBLASTOMA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 33746747484     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.05.013     Document Type: Article

References (29)

1. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1 (2000) 120-129
2. Corsini G.U., Pintus S., Bocchetta A., Piccardi M.P., and Del Zompo M. Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro. J Neural Transm Suppl 22 (1986) 55-60
3. Miguel H., Giancarlo L., and Luis A.G. A prospective study of alcoholism and the risk of Parkinson's disease. J Neurol 251 (2004) VII/14-VII/17
4. Przedborski S., and Jackson-Lewis V. Mechanisms of MPTP toxicity. Mov Disord 13 (1998) 35-38
5. Knapp P. Colloquium C01, Mechanisms of HIV-induced neuropathology, a critical role for astroglia, microglia, and HIV-opiate interactions. J Neuro Chem 94 (2005) 6
6. Poo M.M. Plenary Talk P01: experience-dependent modification of neural circuits-cellular and molecular mechanisms. Neuro Chem 94 (2005) 1
7. Yang J., Liu X., Bhalla K., Kim C.N., Ibrad A., and Cai J. Prevention of apoptosis by Bcl-2, release of cytochrome c from mitochondria blocked. Science 275 (1997) 1129-1132
8. Cropton M. Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr Opin Cell Biol 12 (2000) 414-419
9. Thornberry N.A., and Lazebnik Y. Caspase: enemies within. Science 281 (1998) 1312-1316
10. Lawrence J., Marnett J.N.R., and James D.W. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest 111 (2003) 583-593
11. Scherer P.E., Williams S., Foghane M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
12. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271 (1996) 10697-10703
13. Mandel S., Grunblatt E., Riederer P., Levites Y., and Youdium M.B.H. Neuroprotective strategies in Parkinson's disease, an update on progress. CNS Drugs 17 (2003) 729-762
14. Nakano Y., Tobe T., Choi-miura N.H., Mazda T., and Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 120 (1996) 803-812
15. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295
16. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Hotta K., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
17. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
18. Beers Jr. R.F., and Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195 (1952) 133-140
19. Lebel C.P., Ali S.F., Mckee M., and Bondy S.C. Organomeal-induced increases in oxygen radical species, the potential of 2,7-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol Appl Pharmacol 104 (1990) 17-24
20. +) cytotoxicity. Biochem Biophys Res Commun 137 (1986) 303-309
21. Kehrer J.P., and Smith C.V. Free radicals in biology: sources, reactivities, and roles in the etiology of human diseases. In: Frei B. (Ed). Natural antioxidants in human health and disease (1994), Academic Press, San Diego 25-62
22. Motoshima H., Wu X., Mahadev K., and Goldstein B.J. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 315 (2004) 264-271
23. Cory S., and Adams J.M. The Bcl-2 family, regulators of cellular life-or-death switch. Nat Rev Cancer 2 (2002) 647-656
24. Jankala H., Eriksson C.J., Eklund K.K., Harkonen M., and Maki T. Combined calcium carbimide and ethanol treatment induces high blood acetaldehyde levels, myocardial apoptosis and altered expression of apoptosis-regulating genes in rat. Alcohol Alcohol 37 (2002) 222-228
25. Nicholls D.G., and Budd S.L. Mitochondria and neuronal survival. Physiol Rev 80 (2000) 315-360
26. Kluck R.M., Martin S.J., Zhou J.S., Green D.R., and Newmeyer D.D. Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J 16 (1996) 4639-4649
27. Seaton T.A., Cooper J.M., and Schapria A.H. Free radical scavengers protect dopaminergic cell line from apoptosis induced by mitochondrial complex I toxins. Brain Res 777 (1997) 110-118
28. Hartmann A., Hunot S., Michel P.P., Mureil M.P., Vyas S., Faucheux B.A., et al. Caspase-3, a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 97 (2000) 2875-2880
29. Mandel S., Grunblatt E., Riederer P., Levites Y., and Youdium M.B.H. Neuroprotective strategies in Parkinson's disease, an update on progress. CNS Drugs 1410 (2003) 195-213